about
Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid IntermediatesThe Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes MellitusPlasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American womenCeramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosisSusceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver DiseaseAblation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitroOverexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivitySystems biology analysis merging phenotype, metabolomic and genomic data identifies Non-SMC Condensin I Complex, Subunit G (NCAPG) and cellular maintenance processes as major contributors to genetic variability in bovine feed efficiency.Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesAn inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceSystematic lipidomic analysis of yeast protein kinase and phosphatase mutants reveals novel insights into regulation of lipid homeostasis.Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids.Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistanceInflammatory links between obesity and metabolic disease.Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscleAltered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study.Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.DHA reduces the atrophy-associated Fn14 protein in differentiated myotubes during coculture with macrophages.Sphingosine-1-phosphate signaling and its role in disease.Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.Targeting ceramide synthesis to reverse insulin resistance.Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial functionFAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling.Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes MellitusSphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).Brain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedCeramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complexRegulation of sphingolipid synthesis through Orm1 and Orm2 in yeastSerum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo.Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinomaMechanisms of lipotoxicity in the cardiovascular system.Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.A novel function of adipocytes in lipid antigen presentation to iNKT cells.Sphingolipid metabolism and obesity-induced inflammation.Reducing signs of aging and increasing lifespan by drug synergy.
P2860
Q26739957-A4059759-66F0-4F33-9CD7-7F0409AF9C1DQ26766749-18139E0F-A8FF-4E8C-A3EA-51953350A74DQ28476486-946EBB53-8E41-44C2-B198-50D08F1895FBQ28547365-1A146523-BE9D-4DB4-A4E3-AC44F4FD1A3CQ28551941-6D6DFFCC-F64F-4DFF-935C-86699956181CQ28595077-5E7375D0-D75D-4371-9863-B26F3B3F9877Q30423827-4021DC4A-7EA1-448D-A105-744C3B9A91A9Q30932595-7F6FD117-3ECE-43A7-9FC6-3A45B1BBCC44Q33789323-71D96AE5-D1A9-4740-BBE0-24C8E570E4ACQ34269858-4A082519-99D9-44BE-BC46-3A6682D43242Q34288447-76E248B1-8FD7-4474-925C-1B34F532F9B6Q34327061-FECCB808-D0BE-4AEC-A4FC-4B5D1199663FQ34338023-BDE4BE41-A409-4249-9C5A-A5FF0729C857Q34506779-CECF2401-306B-4608-879A-09A69496A174Q34947370-96CE325A-EE00-4B5F-92D1-A0064AE727BEQ35015802-77DA62E9-5590-4FA4-B7FC-416491384941Q35222194-171D5318-17B9-47B1-B6C5-C65F63A9977DQ35380194-B4F21002-2C62-48D5-82FA-B699A0D8B2A7Q35555867-2541CA99-9D45-4B5C-8E75-CB49456F3726Q35570971-9D03E439-A1A0-497C-9CCE-0E2D19DC7AE7Q35661485-FC299FB7-A1B3-4C8C-ABD6-82F929BA22F0Q35706788-CCB0E30C-0E31-4110-8585-933C03A0A9A7Q35757184-BC5F5D3E-41A3-48D0-9F70-7A0D81A741C8Q35854385-CD5A8B51-9D08-4226-9511-ABDCCCE0B09FQ35859576-759C6D7D-C4D2-4F70-9154-702AC939125DQ35860169-DC6A5521-3D90-405A-B207-FF56DD8CE741Q35921615-0394DEC1-CE55-4D14-8F50-9C681C4D7786Q35957661-10E755E1-0C96-46F2-97EC-1B377A209060Q35997881-A5238AD6-E946-42FF-99C0-C5156D4B3A6CQ35997884-BC7AA697-AD74-49E3-8657-F8B6AE138330Q36047487-E725A9C2-B105-4FE5-B963-57839ADA8F10Q36058716-4AFCD71F-2743-45CC-8F90-121C7D31781BQ36149981-1358ACDE-3A7B-44E7-948F-186833DB161CQ36186252-14E98417-F816-40BA-8C0E-5555A166F7B2Q36308931-F0246712-5E6D-4C1C-AAA6-F767992B9527Q36377252-4C82772C-5F43-4291-B92C-DBF66E578814Q36380756-E862697F-6637-44C3-A4EE-88744B9AA6E5Q36559670-57B72A8C-742D-4B30-92A3-8C3F1C453473Q36898608-A65C873A-2337-4A07-A101-4A694CAE899CQ37022133-7692D65B-2B93-47F3-9E1E-CB7AFCE6AD2C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sphingolipids and insulin resistance: the five Ws.
@en
Sphingolipids and insulin resistance: the five Ws.
@nl
type
label
Sphingolipids and insulin resistance: the five Ws.
@en
Sphingolipids and insulin resistance: the five Ws.
@nl
prefLabel
Sphingolipids and insulin resistance: the five Ws.
@en
Sphingolipids and insulin resistance: the five Ws.
@nl
P1476
Sphingolipids and insulin resistance: the five Ws.
@en
P2093
Scott A Summers
P304
P356
10.1097/MOL.0B013E3283373B66
P577
2010-04-01T00:00:00Z